Lipigon Pharmaceuticals AB (publ) (STO:LPGO)
Sweden
· Delayed Price · Currency is SEK 0.0029
-0.0003 (-9.38%)
Apr 29, 2026, 2:56 PM CET
STO:LPGO Market Cap
STO:LPGO has a market cap or net worth of 1.94 million as of April 29, 2026. Its market cap has decreased by -88.87% in one year.
Market Cap
1.94M
Enterprise Value
-8.28M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.00
Market Cap Chart
Since March 1, 2021, STO:LPGO's market cap has decreased from 97.91M to 1.94M, a decrease of -98.02%. That is a compound annual growth rate of -53.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 1.94M | -62.79% |
| Dec 30, 2025 | 5.21M | -69.56% |
| Dec 30, 2024 | 17.12M | -68.59% |
| Dec 29, 2023 | 54.49M | 240.70% |
| Dec 30, 2022 | 15.99M | -74.72% |
| Dec 30, 2021 | 63.26M | -35.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Stayble Therapeutics AB | 2.92M |
| ExpreS2ion Biotech Holding AB | 7.84M |
| Aptahem AB | 14.22M |
| Fluicell AB | 18.27M |
| Guard Therapeutics International AB | 20.65M |
| NanoEcho AB | 20.96M |
| Biosergen AB | 23.72M |
| 2cureX AB | 51.21M |